Liberated Solutions, Inc. (LIBE PK), doing business as Ngen Technologies USA Corp (the “Company”) is engaged in the business of automotive technology, biomedical technology, and glasses free 3D display technology. On September 16, 2019, the Company closed a share exchange between the Company, Ngen Technologies USA Corp, a Texas corporation (“Ngen”), the shareholders of Ngen, and Brian Conway, the former Chief Executive Officer of the Company, pursuant to which Ngen became a wholly owned subsidiary of the Company, as disclosed on the Form 8-K filed by the Company on September 16, 2019. The Form 8-K included the Company’s audited financial results for its fiscal year ended December 31, 2017 and 2018, and the unaudited results for the 3 and 6 months ending March and June 2019.
Edward Carter, the current Chief Executive Officer of the Company and Co-Founder of Ngen, commented: “We are very excited to finally have the opportunity to release to the market the results of our team’s hard work over the past several years. We will continue to make our investor base aware of corporate changes including our proposed reverse split, name change and symbol change as they occur.” Carter went on to say, “we feel these positive moves will position our company for a more realistic opportunity to up-list to a more senior exchange in the future. We also feel the proposed changes will maximize valuation and make our company more attractive to a new market of investors and institutions.”
The Company is engaged in the business of automotive technology, biomedical technology, and glasses free 3D display technology. Through Ngen Technologies Korea Ltd (“Ngen Korea”), a wholly owned subsidiary of Ngen, the Company currently designs, develops, and sells technology that enables glasses free 3D display for use in smartphones, televisions, and tablets, which we refer to collectively as its “Glasses Free 3D Technologies.” The Company also designs, develops, and sells automotive technologies, and has developed a silencer/muffler system that enables greater fuel efficiency for automobiles. Through its holdings in Emotek Corporation, a Taiwan based company that is jointly owned with Egismos Technologies Corporation, a manufacturer of laser-based light sources, the Company is also seeking to introduce innovative biomedical products, including a tumor detection scanner using laser and Micro-Electro-Mechanical Systems.
Cautionary Statement Concerning Forward-Looking Statements
This press release contains “forward-looking statements”. All statements, other than statements of historical fact, including those with respect to the Company’s mission statement and growth strategy, are “forward-looking statements.” Although the Company’s management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking statements involve many risks and uncertainties, which could cause the Company’s future results to differ materially from those anticipated. Potential risks and uncertainties include, among others, general economic conditions and conditions affecting the industries in which the Company operates; the uncertainty of regulatory requirements and approvals; and the ability to obtain necessary financing on acceptable terms or at all. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company’s filings with the Securities and Exchange Commission. The Company assumes no obligation to update any of the information contained or referenced in this press release.
The market price of our common stock has been, and is likely to continue to be, volatile for the foreseeable future. The market price of our common stock may fluctuate significantly in response to numerous factors, many of which are beyond our control.
More detailed information about the Company and the risk factors that may affect the realization of forward looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Form 8-K filed on September 16, 2019. Investors and security holders are urged to read these documents free of charge on the SEC’s web site at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.